These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 12618684)

  • 21. Endovascular venous thrombolysis in children younger than 24 months.
    Kukreja KU; Lungren MP; Patel MN; Johnson ND; Racadio JM; Dandoy C; Tarango C
    J Vasc Interv Radiol; 2014 Aug; 25(8):1158-64. PubMed ID: 24909354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catheter-Directed Thrombolysis With a Continuous Infusion of Low-Dose Alteplase for Subacute Proximal Venous Thrombosis: Efficacy and Safety Compared to Urokinase.
    Gong M; He X; Song J; Zhao B; Shi W; Chen G; Gu J
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1333-1339. PubMed ID: 29768935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of new thrombolytic substances].
    Zeymer U; Neuhaus KL
    Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacomechanical thrombectomy of acute deep vein thrombosis with the Trellis-8 isolated thrombolysis catheter.
    O'Sullivan GJ; Lohan DG; Gough N; Cronin CG; Kee ST
    J Vasc Interv Radiol; 2007 Jun; 18(6):715-24. PubMed ID: 17538133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group.
    Braithwaite BD; Buckenham TM; Galland RB; Heather BP; Earnshaw JJ
    Br J Surg; 1997 May; 84(5):646-50. PubMed ID: 9171752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Local thrombolysis in peripheral arterial occlusion].
    Hess H
    Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activator.
    Stassen JM; Juhan-Vague I; Alessi MC; De Cock F; Collen D
    Thromb Haemost; 1987 Oct; 58(3):947-50. PubMed ID: 2829381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombolytic therapy with use of alteplase (rt-PA) in peripheral arterial occlusive disease: review of the clinical literature. The Advisory Panel.
    Semba CP; Murphy TP; Bakal CW; Calis KA; Matalon TA
    J Vasc Interv Radiol; 2000 Feb; 11(2 Pt 1):149-61. PubMed ID: 10716384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolytic therapy for arterial occlusion: a mixed blessing.
    Smith CM; Yellin AE; Weaver FA; Li KM; Siegel AE
    Am Surg; 1994 May; 60(5):371-5. PubMed ID: 8161090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous mechanical thrombectomy combined with catheter-directed thrombolysis in the treatment of symptomatic lower extremity deep venous thrombosis.
    Shi HJ; Huang YH; Shen T; Xu Q
    Eur J Radiol; 2009 Aug; 71(2):350-5. PubMed ID: 18524519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study.
    Ouriel K; Katzen B; Mewissen M; Flick P; Clair DG; Benenati J; McNamara TO; Gibbens D
    J Vasc Interv Radiol; 2000; 11(7):849-54. PubMed ID: 10928520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis.
    Lin PH; Zhou W; Dardik A; Mussa F; Kougias P; Hedayati N; Naoum JJ; El Sayed H; Peden EK; Huynh TT
    Am J Surg; 2006 Dec; 192(6):782-8. PubMed ID: 17161094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short- and long-term results after thrombolytic treatment of deep venous thrombosis.
    Schweizer J; Kirch W; Koch R; Elix H; Hellner G; Forkmann L; Graf A
    J Am Coll Cardiol; 2000 Oct; 36(4):1336-43. PubMed ID: 11028492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight-based rt-PA thrombolysis protocol for acute native arterial and bypass graft occlusions.
    Arepally A; Hofmann LV; Kim HS; Geschwind JF; Kirkwood S; Oechsle D; Perler B
    J Vasc Interv Radiol; 2002 Jan; 13(1):45-50. PubMed ID: 11788694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of retavase and urokinase for management of spontaneous subclavian vein thrombosis.
    Gelabert HA; Jimenez JC; Rigberg DA
    Ann Vasc Surg; 2007 Mar; 21(2):149-54. PubMed ID: 17349354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial clinical results of tenecteplase (TNK) in catheter-directed thrombolytic therapy.
    Razavi MK; Wong H; Kee ST; Sze DY; Semba CP; Dake MD
    J Endovasc Ther; 2002 Oct; 9(5):593-8. PubMed ID: 12431142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacoeconomic considerations in peripheral arterial thrombolytic therapy.
    Kaul AF
    J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):104S-110S. PubMed ID: 8770852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry.
    Mewissen MW; Seabrook GR; Meissner MH; Cynamon J; Labropoulos N; Haughton SH
    Radiology; 1999 Apr; 211(1):39-49. PubMed ID: 10189452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cost-benefit study of different thrombolytic strategies in treating 156 patients with symptomatic pulmonary thromboembolism].
    Li XS; Deng XY; Liu HL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Jun; 24(6):355-6. PubMed ID: 22681664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.